Trial Profile
Single Dose Crossover Comparative Bioavailability Study To Assess the Effect of Food on the Pharmacokinetics of Ondansetron Modified-Release Capsules (EUR1025) in Healthy Male and Female Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Ondansetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting; Nausea and vomiting; Postoperative nausea and vomiting; Radiotherapy-induced nausea and vomiting
- Focus Pharmacokinetics
- Sponsors Eurand
- 27 May 2009 New trial record
- 27 May 2009 New trial record
- 19 May 2009 Company added as trial sponsor and additional lead trial centre identified as reported by ClinicalTrials.gov (NCT00981487).